BARBOLINI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.618
EU - Europa 2.395
AS - Asia 2.351
SA - Sud America 350
Continente sconosciuto - Info sul continente non disponibili 68
AF - Africa 53
OC - Oceania 13
Totale 9.848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.481
IT - Italia 795
SG - Singapore 703
CN - Cina 543
GB - Regno Unito 368
IE - Irlanda 316
VN - Vietnam 248
BR - Brasile 238
HK - Hong Kong 234
BD - Bangladesh 188
DE - Germania 185
SE - Svezia 149
FI - Finlandia 117
FR - Francia 111
RU - Federazione Russa 87
CA - Canada 82
IN - India 67
ID - Indonesia 64
KR - Corea 52
TR - Turchia 49
JP - Giappone 39
AR - Argentina 37
UA - Ucraina 37
NL - Olanda 30
BE - Belgio 28
MX - Messico 26
BG - Bulgaria 25
LT - Lituania 24
PL - Polonia 24
CO - Colombia 23
ES - Italia 20
MY - Malesia 20
TW - Taiwan 19
IQ - Iraq 18
VE - Venezuela 16
CZ - Repubblica Ceca 14
CL - Cile 13
EC - Ecuador 13
IR - Iran 13
AT - Austria 12
SA - Arabia Saudita 12
ZA - Sudafrica 12
AU - Australia 11
AE - Emirati Arabi Uniti 9
EU - Europa 9
MA - Marocco 9
PK - Pakistan 9
AL - Albania 8
CR - Costa Rica 8
UZ - Uzbekistan 8
TH - Thailandia 7
EG - Egitto 6
JM - Giamaica 6
KE - Kenya 6
NP - Nepal 6
IL - Israele 5
MT - Malta 5
RO - Romania 5
RS - Serbia 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
JO - Giordania 4
OM - Oman 4
PH - Filippine 4
BH - Bahrain 3
DZ - Algeria 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
GA - Gabon 2
HN - Honduras 2
LV - Lettonia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
DJ - Gibuti 1
Totale 9.776
Salva come PNG Salva come JPEG
Città #
Ashburn 617
Singapore 445
Santa Clara 422
San Jose 355
Dublin 314
Chandler 310
Hong Kong 222
Fairfield 219
Council Bluffs 179
Dallas 160
Southend 150
Hefei 142
Beijing 120
Woodbridge 113
Nyköping 112
New York 106
Helsinki 104
Ann Arbor 99
Seattle 99
London 92
Houston 90
Wilmington 90
Ho Chi Minh City 82
Los Angeles 82
Modena 79
Cambridge 72
The Dalles 64
Hanoi 62
Milan 60
Dearborn 59
Seoul 51
Jakarta 45
Lauterbourg 45
Rome 43
Bologna 41
Jacksonville 40
Munich 40
Moscow 37
Shanghai 35
Fremont 34
Chicago 33
São Paulo 30
San Diego 28
Redwood City 27
Buffalo 24
Columbus 24
Sofia 24
Orem 23
Princeton 23
Tokyo 23
Brussels 22
Toronto 22
Frankfurt am Main 19
San Giuliano Milanese 19
Paris 18
Parma 18
Phoenix 18
Reggio Emilia 18
Bremen 17
Dong Ket 17
Warsaw 17
Brooklyn 15
Eugene 15
Montreal 15
Redondo Beach 15
Falls Church 14
Mumbai 14
Portsmouth 14
Boardman 13
Florence 13
Denver 12
Düsseldorf 11
Guangzhou 11
Haiphong 11
New Taipei 11
Izmir 10
Naples 10
Nuremberg 10
Springfield 10
Atlanta 9
Charlotte 9
Chennai 9
Genoa 9
Poplar 9
Salt Lake City 9
Baghdad 8
Bari 8
Brno 8
Caprarola 8
Cardiff 8
Da Nang 8
Glasgow 8
Kent 8
Mexico City 8
Stockholm 8
Tashkent 8
Istanbul 7
Johannesburg 7
Manchester 7
Medellín 7
Totale 6.389
Salva come PNG Salva come JPEG
Nome #
GD2 expression in breast cancer. 438
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 417
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 410
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 395
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 381
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 381
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 373
The evolving role of microsatellite instability in colorectal cancer: A review 370
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 370
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 362
A concise review of lenalidomide therapy for follicular lymphoma 356
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 333
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 331
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 327
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 325
Breast Location for De Novo Extramedullary Myeloid Sarcoma 308
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 298
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 289
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 288
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 284
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 279
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 277
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 265
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 255
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 248
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 236
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 234
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 216
LETTER TO THE EDITOR: Henoch-schönlein Purpura (HSP) in a Patient on Abemaciclib 208
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 203
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 175
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 171
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. 45
Totale 9.848
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.246
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022469 0 0 0 22 27 55 31 38 58 43 113 82
2022/20231.154 84 128 89 80 82 91 26 84 367 32 46 45
2023/2024648 31 35 62 65 61 57 78 62 35 36 64 62
2024/20251.718 58 35 61 119 325 239 131 108 188 106 140 208
2025/20263.705 238 98 317 331 447 219 528 198 359 363 280 327
2026/2027642 113 191 267 71 0 0 0 0 0 0 0 0
Totale 9.848